Please provide your email address to receive an email when new articles are posted on . The FDA cleared the Eagle device for selective laser trabeculoplasty. Laser energy is delivered in a noncontact ...
ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...
CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...
"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular ...
Eyes that switched from eye drops to SLT had a significant reduction in the average number of medications. Eyes with uncontrolled IOP benefited from SLT, but some still needed trabeculectomy.
More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...
More than 70 million people worldwide suffer from glaucoma, a condition that causes a build-up of fluid and pressure inside the eye and can eventually lead to blindness. Treatment options have ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback